Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

Contact information


gurdeep.mannu@nds.ox.ac.uk


+44 (0)1865 743743


https://www.nds.ox.ac.uk/research/surgical-epidemiology

Gurdeep S. Mannu

Cancer Research UK (CRUK) Clinician Scientist

  • Associate Professor
  • Honorary Consultant Oncoplastic Breast Surgeon
  • Senior Clinical Research Fellow in Cancer Surgery
  • Previous NIHR Academic Clinical Lecturer in General Surgery

Having completed his undergraduate studies in London, Gurdeep started his training in the East of England deanery. He then moved to Oxford to complete his specialist training in general surgery. He was then awarded an NIHR academic clinical lecturership in general surgery alongside his clinical research fellowship in cancer surgery.   His research interest is in cancer epidemiology.

Study assesses long term risk of invasive breast cancer after pre-invasive disease

What are the long term risks of invasive breast cancer and death related to breast cancer after non-screen detected ductal carcinoma in situ? Author, Mr Gurdeep S. Mann, explains the study's findings.

Recent publications

Identification of recurrences in women diagnosed with early invasive breast cancer using routinely collected data in England.

Journal article

Probert J. et al, (2025), BJC Rep, 3

Invasive breast cancer and breast cancer death after non-screen detected ductal carcinoma in situ from 1990 to 2018 in England: Population based cohort study

Journal article

Mannu GS. et al, (2024), BMJ

Overview of Axillary Treatment in Early Breast Cancer: patient-level meta-analysis of long-term outcomes among 20,273 women in 29 randomised trials

Journal article

Mannu G. et al, (2024), CANCER RESEARCH, 84

Ki67 and breast cancer mortality in women with invasive breast cancer

Journal article

Probert J. et al, (2023), JNCI Cancer Spectrum, 7

Anthracycline-containing and taxane-containing chemotherapy for early-stage operable breast cancer: a patient-level meta-analysis of 100 000 women from 86 randomised trials.

Journal article

Early Breast Cancer Trialists’ Collaborative Group (EBCTCG). Electronic address: bc.overview@ctsu.ox.ac.uk . and Early Breast Cancer Trialists’ Collaborative Group (EBCTCG) ., (2023), Lancet, 401, 1277 - 1292